FGF19 and nasopharyngeal carcinoma: Shi et al. reported that FGF19 was highly upregulated in MSC-Exos to activate the FGF19-FGFR4-dependent ERK signaling cascade and modulate EMT to promote nasopharyngeal carcinoma (NSC) [64].